Hereby, we present a patient who had low ejection fraction, aortic and mitral valve replacement history with recurrent episodes of VT, and was not able to be planned invasive catheter ablation.
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Ventricular tachycardia (VT) episodes may be fatal in patients with low ejection fraction.
📊
Temel Bulgular & Veri:Current guidelines recommend implantable cardioverter defibrillator implantation after optimal medical treatment for these patients.
💡
Sonuç & Katkı:Hereby, we present a patient who had low ejection fraction, aortic and mitral valve replacement history with recurrent episodes of VT, and was not able to be planned invasive catheter ablation.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri
Özet
Ventricular tachycardia (VT) episodes may be fatal in patients with low ejection fraction. Current guidelines recommend implantable cardioverter defibrillator implantation after optimal medical treatment for these patients. Catheter ablation therapies should be considered in recurrent VT episodes. However, treatment options are limited in patients who cannot undergo catheter ablation. Hereby, we present a patient who had low ejection fraction, aortic and mitral valve replacement history with recurrent episodes of VT, and was not able to be planned invasive catheter ablation.
🔖
Bu Makaleye Atıf Yap
SEVGİCAN, C. İ., NAR, G., YILMAZ, S., BİTEKER, M. (2020). Cardiac Resynchronization Treatment Upgrade is An Alternative Treatment Option for Resistant Ventricular Tachycardia After Double Valve Replacement. E Journal of Cardiovascular Medicine, Cilt: 8 - Sayı: 2, 99–102. https://ajindex.com/articles/150669
Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJ S, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J 2016;37:2129-200
Al-Khatib SM, Stevenson WG, Ackerman MJ, Bryant WJ, Callans DJ, Curtis AB, et al. AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol 2018;138:e272–e391
Alvarez CK, Cronin E, Baker WL, Kluger J. Heart failure as a substrate and trigger for ventricular tachycardia. J Interv Card Electrophysiol 2019;56:229-47
Spartalis M, Spartalis E, Tzatzaki E, Tsilimigras DI, Moris D, Kontogiannis C, et al. Novel approaches for the treatment of ventricular tachycardia. (2018); World J. Cardiol 2018;10:52-9
Peichl P, Wichterle D, Pavlu L, Cihak R, Aldhoon B, Kautzner J. Complications of catheter ablation of ventricular tachycardia: a singlecenter experience. Circ. Arrhythm. Electrophysiol 2014;7:684-90
Zei PC, Mak R. Noninvasive Stereotactic Radioablation for Ventricular Tachycardia. Circulation 2019;139:322-4
Vurgun VK, Altin AT, Kilickap M, Candemir B, Akyurek O. Percutaneous transapical approach and transcatheter closure for ventricular tachycardia ablation. Pacing Clin. Electrophysiol. 2018;41:334-7.